PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jbcThe Journal of Biological Chemistry
 
J Biol Chem. 2013 June 7; 288(23): 16747–16760.
Published online 2013 April 14. doi:  10.1074/jbc.M112.438416
PMCID: PMC3675608

Glucosylceramide Transferase Activity Is Critical for Encystation and Viable Cyst Production by an Intestinal Protozoan, Giardia lamblia*

Abstract

The production of viable cysts by Giardia is essential for its survival in the environment and for spreading the infection via contaminated food and water. The hallmark of cyst production (also known as encystation) is the biogenesis of encystation-specific vesicles (ESVs) that transport cyst wall proteins to the plasma membrane of the trophozoite before laying down the protective cyst wall. However, the molecules that regulate ESV biogenesis and maintain cyst viability have never before been identified. Here, we report that giardial glucosylceramide transferase-1 (gGlcT1), an enzyme of sphingolipid biosynthesis, plays a key role in ESV biogenesis and maintaining cyst viability. We find that overexpression of this enzyme induced the formation of aggregated/enlarged ESVs and generated clustered cysts with reduced viability. The silencing of gGlcT1 synthesis by antisense morpholino oligonucleotide abolished ESV production and generated mostly nonviable cysts. Interestingly, when gGlcT1-overexpressed Giardia was transfected with anti-gGlcT1 morpholino, the enzyme activity, vesicle biogenesis, and cyst viability returned to normal, suggesting that the regulated expression of gGlcT1 is important for encystation and viable cyst production. Furthermore, the overexpression of gGlcT1 increased the influx of membrane lipids and fatty acids without altering the fluidity of plasma membranes, indicating that the expression of gGlcT1 activity is linked to lipid internalization and maintaining the overall lipid balance in this parasite. Taken together, our results suggest that gGlcT1 is a key player of ESV biogenesis and cyst viability and therefore could be targeted for developing new anti-giardial therapies.

Keywords: Glycolipids, Lipids, Lipid Metabolism, Parasite, Parasite Metabolism, Sphingolipid, Giardia, Glucosylceramide, Transferase

Introduction

Giardiasis, caused by Giardia lamblia, is widespread throughout the world. This intestinal parasite exists in two morphologic forms, trophozoites and cysts. Although trophozoites colonize the small intestine and produce infections, cysts transmit the disease via contaminated water and food (1). Stage-specific differentiation of cyst to trophozoite, which takes place in the human stomach, is known as excystation, whereas the transformation from trophozoites to cysts that occurs in the small intestine is called encystation. Giardial cyst walls contain insoluble filamentous materials made of proteins, glycoproteins, and polysaccharides (25). At the onset of encystation, encystation-specific vesicles (ESVs)3 are synthesized by trophozoites that transport three cyst wall proteins (CWP-1, -2, and -3) to the plasma membrane before laying down the water-resistant cyst wall (5). CWP-1, -2, and -3 are acidic proteins (molecular mass ~26, ~39, and ~27 kDa, respectively) containing similar domains, including N-terminal signal sequences and five tandem, leucine-rich repeats (6, 7). Reports suggest that all three CWPs are essential for forming ESVs and that CWP-2 functions as an aggregation factor by interacting with CWP-1 and CWP-3 via conserved regions (8). Besides these three CWPs, high cysteine, nonvariant cyst protein, and cysteine protease-2 were also shown to participate in the process of encystation and cyst production (5, 9).

Emerging reports indicate that the enzymes and products of sphingolipid (SL) biosynthesis pathways act as regulators of various cellular processes in both lower and higher eukaryotes. For instance, ceramide synthase activity is associated with increased tumor growth and progression in head and neck cancers (10). Sphingosine 1-phosphate has been shown to generate initial signals for apoptotic cell extrusion (11). Ceramidase expression is important for normal retinal function, and the targeted expression of neutral ceramidase in mutant fruit flies rescues photoreceptor degeneration (12). The mutation in the long chain sphingoid base subunit-1 (LCB1) of serine palmitoyltransferase causes autosomal, dominant, peripheral, and sensory neuropathy (13). In plants, the synthesis of four different classes of SLs and glycosphingolipids (GSLs) was observed, including glycosylinositolphosphoceramides, glycosylceramides, ceramides, and free LCBs. Several enzymes of plant SL metabolic pathways have also been cloned and characterized (14). SLs are also critical for regulating various biological processes in unicellular organisms like fungi and protozoa. In budding yeast, SLs contain C26 acyl moieties and are connected with the target of rapamycin complex 2 (TORC2) and phosphoinositide signaling (15). In Leishmania and Trypanosoma parasites, the synthesis of large amounts of nonglycosylated inositol phosphorylceramides, and ethanolamine phosphorylceramides, along with other SLs, have been reported. These SLs in trypanosomatids contribute greatly to the growth and survival of parasites within the host and have important functions during host-parasite interactions (16).

As far as giardial SLs are concerned, only five genes of the entire SL metabolic pathway have been annotated in the Giardia Genome Database, and they are all transcribed differentially between trophozoites and cysts (17). These genes are as follows: (i) giardial serine-palmitoyltransferase-1 and -2 subunit genes (gspt-1 and gspt-2), (ii) glucosylceramide synthase or glucosylceramide transferase 1 (gglct-1), and (iii) two acid sphingomyelinase genes (gasmase 3b and gsmase B). It was reported that d-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP), an inhibitor of glucosylceramide (GlcCer) synthase (GCS or GlcT1), interferes with encystation and cyst production by Giardia, suggesting that GlcCer synthesis is important for encystation (17, 18). Despite this information, the exact mechanisms by which this enzyme and its product regulate the ESV biogenesis and cyst production are still not clear.

This study focuses on understanding the unique and precise function of gGlcT1 and its role in encystation and cyst formation. Here, we report that modulation of gGlcT1 activity by overexpression and knockdown affects the ESV biogenesis and cyst viability of Giardia. We also provide evidence that gGlcT1 overexpression destabilizes lipid balance in this parasite by increasing the influx of lipids, cholesterol, and fatty acids from the culture medium.

EXPERIMENTAL PROCEDURES

Materials

Unless otherwise specified, all chemicals were purchased from Sigma and were of the highest purity available. Tetramethylrhodamine (TMR)-conjugated goat anti-mouse antibodies, fluorescent (Bodipy- or NBD-conjugated) lipids, 1,1′-dilinoleyl-3,3,3′,3′-tetramethylindocarboxyanine (FAST Dil), and 4′,6-diamidino-2-phenylindole (DAPI) were purchased from Invitrogen. PPMP and other lipid standards, including 13C-deuterated GM3, were purchased from Matreya LLC (Pleasant Gap, PA). Glucosylceramide and lactosylceramide were obtained from Avanti Polar Lipids (Alabaster, AL). Anti-giardial cyst and anti-AU1 antibodies (monoclonal) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and Covance Laboratory (San Diego, CA), respectively. UDP-[14C]glucose (300 mCi/mmol) was purchased from American Radiolabeled Chemical (St. Louis, MO).

Trophozoites, Encysting Cells, and the Generation of in Vitro Cysts

G. lamblia trophozoites (strain WB, ATCC No. 30957) were cultivated following the method of Diamond et al. (19) using modified TYI-S-33 medium supplemented with 5% adult bovine serum and 1% bovine bile (20). The antibiotic piperacillin (100 μg/ml) was added during routine culturing of the parasite (21). Trophozoites were detached from the culture flask by ice chilling and harvested by centrifugation at 1500 × g for 10 min at 4 °C, followed by three washings in sterile PBS and microscopic determination of cell numbers using a hemocytometer. In vitro encystation was carried out by culturing the trophozoites in TYI-S-33 medium, pH 7.8, supplemented with adult bovine serum (10%, v/v), lactic acid (5 mm), and porcine bile (250 mg/ml) for various time points, as described below (21). Cells were allowed to encyst for 72 h, and cysts were isolated by centrifugation (2,500 × g for 10 min at 4 °C), washed three times in cold distilled water, and kept in water for 3 days in a refrigerator (4–8 °C). Isolated water-resistant cysts were counted or subjected to the microscopic experiments also described below.

Overexpression of gGlcT1 in Giardia Trophozoites

For overexpression, a small peptide epitope (AU1)-tagged pNT5 expression plasmid (obtained from Dr. Chin-Hung Sun, Taiwan) containing the gglct1 gene was constructed following the method described by Pan et al. (22). Briefly, the entire open reading frame of gglct1 ORF_11642 was amplified by PCR using the primers 5′-GCGCCATGGATGGACGGGTTGACTCTCTCC-3′ and 5′-GCGGAATTCTCAGATGTATCGATACGTATCGTCGAGGGATTTTTT-3′. The insert was digested with EcoRI/NcoI and ligated into EcoRI/NcoI-digested dephosphorylated pNT5 plasmid (22). This new plasmid pNT5-gglct1 was then transformed into competent DH5α cells and plated onto LB plates containing 100 μg/ml ampicillin. Colonies were screened by PCR, and positive colonies were sequenced at the University of Texas-El Paso DNA core facility. The ABI Prism BigDye Terminator version 3.1 cycling sequencing kit (Applied Biosystems, Carlsbad, CA) was used to amplify the DNA with fluorescently labeled dideoxynucleotides. The sequencing reaction was subsequently cleaned using Agincourt Clean SEQ (Beckman Coulter, Brea, CA). The parasites were placed in a 4-mm electroporation tube (Fisher Biotech, Waltham, MA) in a 300-μl suspension of TYI-SS media; 40 μg of the pNT5-gglct1 plasmid was resuspended in the cell suspension. Trophozoites were then transfected by electroporation on a Gene Pulser X cell (Bio-Rad) using the following parameters: 322 V, 500 microfarads, and ∞Ω resistance (4-mm cuvette). Cells were allowed to recuperate in media overnight after electroporation, followed by selection with 100 μg/ml G418 (Sigma). Stable transfectant trophozoites overexpressing gGlcT1 (+gGlcT1) were established within 2 weeks.

Knockdown of gGlcT1 Expression by Antisense Morpholino Oligonucleotide

Cultured Giardia trophozoites were harvested by centrifugation as described above. Parasites were placed in a 4-mm electroporation tube (Fisher Biotech) in a 300-μl suspension of the media, transfected (using the same setting as the overexpression described above) with anti-gglct1 (5′-CTAAGGAGAGAGTCAACCCGTCCAT-3′), and scrambled (mismatch) with (5′-CCTCTTACCTCAGTTACAATTTATA-3′) morpholino oligonucleotides (custom ordered from Gene Tools, Inc., Philomath, OR) following the protocol described previously by Carpenter and Cande (23). gglct1-knockdown trophozoites were resuspended in media and left to recover for 6 h for additional experimentation.

Assessing PPMP and Morpholino Oligonucleotide-treated Trophozoites

Giardial trophozoites were electroporated with 50 μm of anti-ggclt1 morpholino and/or treated with PPMP (10 μm) for 24 h. Cells were then harvested and mounted with Prolong® Gold antifade reagent (Invitrogen) in a four-well chambered slide as described above without any further treatments. At least 100 singlet, doublet, and triplet trophozoites from 10 different fields were viewed and counted by confocal microscopy (Zeiss-LSM 700) using Zen 2009 software (Carl Zeiss, Irvine, CA). The percentage values of doublet cells were calculated based on the total number of cells (singlet, doublet, and triplet).

Rescue Experiments

The stable transfectants of Giardia trophozoites overexpressing gGlcT1 were generated as described above. gGlcT1-overexpressing trophozoites were then transfected with anti-gGlcT1 morpholino oligonucleotide following the procedure also described above. After antisense morpholino oligonucleotide transfection, gGlcT1-overexpressing trophozoites were allowed to recover for 6 h before conducting the experiments described below.

gGlcT1 Assay

The activity of the gGlcT1 enzyme in Giardia trophozoites, encysting cells, cysts, gGlcT1-overexpressing, and gGlcT1-knockdown cells was measured using the methods described for mammalian and Plasmodium cells (24, 25). Each reaction tube contained phosphate buffer (100 mm, pH 7.4), enzyme extracts (1500 × g supernatant), UDP-[14C]glucose (~100,000 cpm/assay), protease inhibitors (2.5% 1× protease inhibitor mixture, 5 μm E-64), 1 mm MgCl2, 5 mm KCl, 2 mm β-NAD, and the liposomal substrate containing 0.1 nmol of ceramide mixed with dipalmitoylphosphatidylcholine in a ratio of 1:10 (v/v) (total volume, 100 μl). The mixture was incubated for 5 h at 37 °C and extracted with chloroform (CHCl3)/methanol (MeOH), 1:1 v/v, and the formation of enzymatic product ([14C]GlcCer) was assessed by measuring the radioactivity in a scintillation counter (Beckman, Brea, CA). The assay was conducted in the presence and absence of PPMP (10 μm), a common inhibitor of GlcCer synthesis (26).

Synthesis of NBD-C6-Glucosylceramide

NBD-GlcCer synthesis by Giardia was monitored following the method described by Gupta et al. (27). Briefly, cells were harvested and resuspended in PBS supplemented with 1% glucose and 0.2% l-cysteine. A total of 50 μm of NBD-C6 ceramide-BSA complex (Invitrogen) was added and incubated for 5 h at 37 °C. Sphingolipids were extracted in a solvent in a mixture containing 1.3 ml of acetic acid/MeOH (1:50, v/v), 1.3 ml of CHCl3, and 1.3 ml of Milli-Q H2O (28). The lower CHCl3 phase was pooled and dried under nitrogen. Samples were resolved on TLC (Whatman) using the following solution: 170 ml of CHCl3, 30 ml of MeOH, and 2 ml of 3.5 n ammonium hydroxide (NH4OH). The formation of NBD-C6-glucosylceramide was visualized under a UV lamp (27).

Staining with Anti-cyst Antibody

To evaluate the transition from nonencysting to encysting trophozoites and cysts as well as to identify ESVs, cells were labeled with anti-cyst antibody (1:100) and analyzed by confocal microscopy. This anti-cyst antibody purchased from Santa Cruz Biotechnology was raised against intact cysts and therefore recognizes all cyst wall proteins (CWP1, CWP2, and CWP3). Trophozoites were cultivated and subjected to encystation in a cultured medium as described before (21). Cells were harvested, transferred, and fixed to four-chambered slides using 4% paraformaldehyde. Fixed samples were allowed to react with anti-cyst antibody overnight at 6–10 °C, followed by reacting with tetramethylrhodamine-conjugated goat anti-mouse antibody (1:500) (Invitrogen) for 2 h at room temperature. Cells were subsequently mounted with Prolong® Gold antifade reagent mixed with DAPI (Invitrogen). Samples were analyzed in a confocal microscope (Carl Zeiss Laser Scanning Systems LSM 700), using the Zen 2009 software (Carl Zeiss) for acquisition and image analysis.

Labeling Trophozoites with Fluorescent-conjugated Lipid Probes

Control and gGlcT1-overexpressing trophozoites were harvested and allowed to adhere in the Nunc Lab-Tek II 4-well chamber slide (Thermo Fisher Scientific, Inc., Austin, TX) for 30 min at 37 °C. The cells were washed with PBS and incubated with different fluorescent lipid probes, i.e. Bodipy-phosphatidylcholine (Bodipy-PC; 100 nm); NBD-phosphatidylglycerol (NBD-PG, 1 μm); Bodipy-phosphatidylethanolamine (Bodipy-PE, 100 nm); Bodipy-ceramide (200 nm, Bodipy-sphingomyelin (Bodipy-SM, 200 nm); or FAST Dil (1 μm) for 1 h at 37 °C as described previously (28). The cells were then fixed with 4% paraformaldehyde, washed with PBS, mounted with ProLong® Gold Antifade Reagent containing DAPI (Invitrogen), and visualized by confocal microscopy (Carl Zeiss Laser Scanning Systems LSM 700). The fluorescence intensities were quantified with the help of the Zeiss ZEN 2009 confocal software (Carl Zeiss).

Monitoring Cyst Viability

Fluorescein diacetate (FDA) inclusion and propidium iodide (PI) exclusion experiments were performed to monitor cyst viability. Briefly, a 25 mm stock solution of FDA and PI (Sigma) was prepared in 100 mm phosphate buffer, pH 6.0, from which a working solution was made by adding 40 μl of stock to 10 ml of phosphate buffer. gGlcT1-overexpressing and gGlcT1-knockdown trophozoites were subjected to encystation as described above, and the water-resistant cysts were collected by centrifugation. Approximately 107 cysts were subjected to FDA and PI staining as described previously by Gillin et al. (21). Cysts were then washed with PBS, mounted on a slide with DAKO mounting media (DAKO, Carpinteria, CA), and viewed under the Zeiss LSM 700 confocal microscope using Zen 2009 software (Carl Zeiss).

Immunoblotting Analysis

Giardial cells were isolated and resuspended in lysis buffer (5 mm Tris-HCl, 2 mm EDTA, 0.1% Triton X-100, pH 7.4) containing protease inhibitor mixture and E-64 (1 μm, Sigma). The sample was freeze thawed at −80 °C, boiled in sample buffer before being analyzed (40 μg protein/lane) by 10% SDS-PAGE, and followed by immunoblotting analysis on the polyvinylidene fluoride (PVDF) membrane. The membrane was blocked in 1% BSA, incubated with anti-cyst antibody (monoclonal, 1:100), and incubated overnight at 4 °C. The PVDF membrane was then incubated with anti-mouse HRP conjugate (1:10,000; KPL, Inc., Washington, D. C.) for 30 min at room temperature. The enhanced chemiluminescence (ECL) technique was used for the detection of protein bands.

Sterol Analysis by GC-MS

Sterol analysis in control and gGlcT1-overexpressing trophozoites was carried out according to the method of Fridberg et al. (29). Trophozoites (~1 × 108) were grown and harvested as described above, resuspended in CHCl3/MeOH/H2O (1:2:0.8, v/v/v), and centrifuged (1500 × g) at room temperature for 15 min. The supernatant was collected and dried under nitrogen, and the pellet was then extracted with CHCl3/MeOH (2:1, v/v) three times and with CHCl3/MeOH: H2O (1:2:0.8, v/v/v) twice before being dried under a nitrogen stream. The supernatants obtained from these six extractions were pooled together before being dried in the same flask. The dried samples were then submitted to Folch's partition, after first being diluted in CHCl3/MeOH/H2O (4:2:1.5, v/v/v), and then centrifuged (1500 × g) at room temperature for 15 min. This partitioning gave rise to two phases as follows: a lower phase, rich in free fatty acids, sterols, and phospholipids, and an upper phase, rich in inositol phospholipids. The lower phase was dried down with nitrogen gas, resuspended in pure CHCl3, and fractionated through a Silica Gel 60 column according to Pernet et al. (30). The CHCl3 phase of the samples were dried under a nitrogen stream and dissolved in dichloromethane. Fifty ng of external standard (Stigmasterol, Sigma) was added to the giardial sample, and 1 μl of the resulting mixture was injected into the gas chromatographer (Trace GC, Thermo Fisher Scientific) coupled to a mass spectrometer (Polaris Q, Thermo Fisher Scientific) (GC-MS). The fractionation was performed in a TR-5-ms column (30 m × 250 mm × 0.25 μm, Thermo Fisher Scientific). The injector temperature was set at 250 °C. The gradient was set at an initial temperature of 170 °C for 3 min, followed by a 20 °C/min increase up to 280 °C, and then a 17-min hold after the final temperature was achieved. The carrier gas was helium, with a flow rate of 1.2 ml/min. The samples were ionized by electron impact (EI) at 70 eV and 30 °C, and the spectra were collected at the 50–650 m/z range.

Fatty Acid Methylation and GC-MS Analysis

Fatty acids extracted from Giardia were subjected to methylation following the protocol described by Maldonado et al. (31). Briefly, a methanol fraction of lipid extracts from trophozoites (~1 × 108) was dried under nitrogen, resuspended in 13 n NH4OH/MeOH (1:1, v/v), and incubated for 1 h at 37 °C. The sample was then dried under a nitrogen stream, resuspended in MeOH, dried again, and mixed with 0.5 n methanolic HCl. The mixture was incubated for 1 h at 75 °C and then mixed with 0.5 n NaOH to neutralize the reaction before mixing with 750 μl of dichloromethane and H2O (1:1, v/v). This mixture was then centrifuged at 1500 × g for 15 min, and the lower phase was separated. Standards were dissolved in dichloromethane and analyzed by GC-MS (Trace GC/Polaris Q, Thermo Fisher Scientific). The injector was set at 200 °C, and the following gradient was used: 70 °C for 5 min, followed by 4 °C/min up to 140 °C, 2 °C/min up to 185 °C, and 185 °C for 10 min. Helium was used as the carrier gas, with a flow rate of 1 ml/min, and then the molecules were ionized by electron impact at 70 eV and 200 °C. The spectra were collected at the 30–400 m/z range, and fatty acid species were identified by comparison with the FAME 37-methylated fatty acid mix standard (Supelco, Sigma).

Glycosphingolipid Analysis by ESI-MS-MS

Neutral and acidic glycosphingolipids (GSLs) were extracted and separated following the method described by Li et al. (32). Briefly, control, gGlcT1-overexpressed, gGlcT1-knockdown, and gGlcT1-rescued trophozoites (~1 × 109 cells/sample) were harvested, pelleted, and extracted first with CHCl3/MeOH (1:1, v/v) and then with isopropyl alcohol/hexane/H2O (55:25:20, v/v/v) before being subjected to DEAE-Sephadex chromatography. Neutral lipids were eluted with CHCl3/MeOH/H2O (30:60:8, v/v/v). Acidic lipids were eluted with MeOH-containing 0.8 m sodium acetate. Both neutral and acidic GSLs were subjected to methylation as described by Ciucanu and Kerek (33), followed by ESI-MS/MS analysis using an LTQ XL mass spectrometer (Thermo Fisher Scientific). Briefly, samples were mixed with 1 pmol/μl methylated standards (d18:1/C12:0) and introduced via a TriVersa NanoMate nanoelectrospray source (Advion, Ithaca, NY) (capillary temperature 230 °C, with injection time of 100.00 ms, activation time of 30 ms, activation Q value of 0.250, isolation width of m/z 2.0, and acquisition time of 0.5 min). Quantitation was achieved using select reaction monitoring with collision energy set to 50 for all samples. For hexosylceramide reactions, singly charged parent ions with sodium adduct ([M + Na+]+) were fragmented and monitored for the fragment ions of permethylated hexose [C10H20O6 + Na]+ (from monohexosylceramide), permethylated dihexose [C19H36O11 + Na+]+ (from dihexosylceramide), or permethylated trihexose [C28H52O16 + Na+]+ (from trihexosylceramide). For the acidic GSLs (i.e. GM1, GM3, and GD3), the loss of a methylated sialic acid fragment at 376 Da was monitored [M + Na+]+/[M + Na − C17H30NO8]. Hexosylceramide was normalized to the internal standard d18:1/C12:0-glucosylceramide (Avanti Polar Lipids), and dihexosylceramide and trihexosylceramide were normalized to the internal standard d18:1/C12:0-lactosylceramide (Avanti Polar Lipids). GM3, GD3, and GM1 were normalized to 13C-deuterated d18:1/C18:0-GM3 standard (obtained from Matreya). Because of differences in ionization efficiencies between individual lipids, relative abundance was calculated rather than absolute mass of each lipid class.

Membrane Fluidity Assay

Approximately 107 trophozoites (control and gGlcT1-overexpressing) were grown and harvested as described above, and the cells were analyzed using the membrane fluidity kit (M0271, Marker Gene Technologies, Inc., Eugene, OR). Cold-shock trophozoites (4 °C, 30 min) were used as positive control. The cells were resuspended in 200 μl of perfusion buffer with 20 μm fluorescent lipid reagent (pyrene decanoic acid) and 0.08% of pluronic F127, provided with the kit. The suspension was shaken on a rocker for 1 h at RT, and the cells were then washed with PBS and subsequently analyzed using the ISS K2 Multifrequency Phase and Modulation Fluorometer (ISS, Inc., Champaign, IL). The samples were excited at 341 nm, and the emission spectra were recorded at 360–500 nm. Crossed polarizers on excitation and emission beams were used to reduce the background because of scatter. The emission spectra were then appended with normalized intensities using VINCI software (ISS).

Statistical Analysis

All values were given as mean values ± S.D., and statistical analyses were generated using SAS software version 9.2 (SAS Institute, Cary, NC) and Graphpad Quickcalcs. In experiments with three or more variables, the F-test was performed, and in experiments with two variables the Student's t test was performed. Statistical values less than 0.01 were considered highly significant, whereas values less than 0.05 were considered significant. The variances of MS data for GSLs were calculated by one-way analysis of variance.

RESULTS

gGlcT1 Activity Is Elevated during Encystation

Earlier reports from this laboratory and other laboratories have indicated that GlcCer, a precursor of wide varieties of GSLs, play an important role during encystation by Giardia (17, 18). It was observed that the transcript of the gGlcT1 gene (gglct1) is up-regulated in encysting cells and that PPMP, an inhibitor of GlcCer synthesis (34, 35), inhibits the cyst production in culture (17). In this study, we asked if Giardia synthesizes the active gGlcT1 enzyme and uses it to drive the process of encystation. Therefore, gGlcT1 activity was measured in the cell-free extracts (1500 × g supernatant) of nonencysting and encysting trophozoites as well as in water-resistant cysts using UDP-[14C]glucose and ceramide (24, 25). Results show that the basal gGlcT1 activity is low in nonencysting trophozoites and up-regulated in 12- and 24-h encysting cells and increases severalfold in cysts (Fig. 1A). We found that the gGlcT1 activities in trophozoites and encysting cells were inhibited by PPMP, which that bears a resemblance to both the ceramide and GlcCer (34, 35). However, unlike trophozoites and encysting cells, the cyst enzyme was completely resistant to PPMP (Fig. 1A). Next, we generated GlcT1 knockdown Giardia where the gglct1 gene was silenced by morpholino oligonucleotide. Knockdown by morpholino analogs is a faster and more efficient way to silence genes in Giardia (23). In recent years, various laboratories have successfully used antisense morpholino oligonucleotides to knock down giardial kinesin and flagellar genes. The effects of antisense morpholinos are transient and last for 72 h, which is sufficient to carry out one round of the encystation cycle (36). As shown in Fig. 1B, knockdown by anti-gGlcT1 morpholino reduced the gGlcT1 activity in cysts by ~60%. This result suggests that although resistant to PPMP, cyst gGlcT1 could be inhibited by anti-gGlcT1 morpholino, which blocks the translation initiation of gGlcT1 by targeting the 5′ region of the gglct1 gene. However, PPMP competes with ceramide for the catalytic site of gGlcT1 and is thereby expected to inhibit the enzymatic reaction (34).

FIGURE 1.
GlcT1 activity in encysting Giardia. A, gGlcT1 activity in nonencysting, encysting (12- and 24-h), and water-resistant cysts was measured in the cell-free extracts using [14C]UDP-glucose (~100,000 cpm/assay) and ceramide as substrates. The reaction ...

Synthesis of GlcCer, the reaction product of gGlcT1, was also monitored by assessing NBD-GlcCer synthesis by encysting cells. For this, both nonencysting and encysting Giardia trophozoites were labeled with NBD-C6-ceramide, and the product was analyzed by TLC. Fig. 1C shows that the synthesis of NBD-GlcCer is extremely low (almost nonvisible in the photograph) in trophozoites and increases during encystation. However, we found that the formation of NBD-GlcCer in 12-h encysting cells is slightly higher than in 24-h encysting cells, which could be due to the fact that cells at the later stage of encystation (i.e. 18 h onwards) start forming cyst walls and become increasingly impermeable to NBD-ceramide and other molecules (data not shown). Therefore, in this study, no attempt was made to label the cyst with NBD-GlcCer. The increased synthesis of NBD-GlcCer during 12- and 24-h encysting Giardia supports our enzymatic results (Fig. 1A) that encystation stimuli induce gGlcT1 activity, leading to the synthesis of GlcCer.

Modulation of gGlcT1 Activity Affects ESV Biogenesis

Giardia has a relatively simple life cycle, i.e. replicative trophozoites and relatively dormant cysts. During encystation in the small intestine, trophozoites synthesize ESVs that are necessary to transport CWPs to plasma membranes (37). ESVs are synthesized in the endoplasmic reticulum (ER), located in the perinuclear membranes/cytoplasm in early encysting cells, and then distributed extensively in the periphery of the cell (in close proximity to peripheral vacuoles) in the late encystation phase (38). Because of the presence of Golgi-like cisternae in ESVs, these sorting vesicles are also considered as a primitive Golgi complex of Giardia (39). Over the years, many investigators have studied encystation and identified various proteins and genes that are associated with the process (see Ref. 5 for review). However, nothing is known about how the ESV biosynthesis is regulated and participates in viable and infective cyst formation. Because gGlcT1 activity is up-regulated during encystation (Fig. 1A), we had thought that gGlcT1 was linked to ESV biogenesis. To test this, control and gGlcT1-knockdown trophozoites were subjected to encystation for 18 h, and ESV synthesis was monitored using an anti-cyst antibody that recognizes early and late ESVs as well as the cyst walls (40). It was observed that anti-gGlcT1 morpholino oligonucleotide, which inhibited gGlcT1 activities in trophozoites and cysts, was found to block ESV biogenesis completely (Fig. 2A). However, ESV synthesis by encysting cells that were transfected with scrambled morpholino oligonucleotide (labeled as control (scrambled) in Fig. 2A) was not affected at all. To further elucidate the role of gGlcT1 in ESV biogenesis, we overexpressed the gglct1 gene in trophozoites and subjected them to encystation. Fig. 2B shows that gGlcT1 overexpression produces aggregated and enlarged ESVs as compared with control cells that were transfected with empty plasmid. This indicates that the modulation of gGlcT1 activity either by knockdown or overexpression affects ESV biosynthesis in Giardia. The specificity of anti-cyst antibody used in this study is shown in Fig. 2C, which reveals that this antibody recognizes cyst wall proteins (CWP1, CWP2, and CWP3) that are synthesized during encystation.

FIGURE 2.
Knockdown and overexpression of gGlcT1 affects ESV biogenesis. A, Giardia trophozoites were transfected with anti-gGlcT1 morpholino oligonucleotide (50 μm) (23) and subjected to encystation for 24 h before ESVs were analyzed by confocal microscopy. ...

Fig. 3A demonstrates that gGlcT1 activity in overexpressed trophozoites increased ~3-fold as compared with the activity present in control trophozoites (i.e. specific activities increased from 0.5 pmol/min/mg protein in control to 1.4 pmol/min/mg protein in gGlcT1-overexpressing cells). Knockdown by anti-gGlcT1 morpholino oligonucleotide inhibits gGlcT1 activity in trophozoites by ~50% (from 0.5 to 0.24 pmol/min/mg protein). Furthermore, the rescue experiment (i.e. transfecting gGlcT1-overexpressing trophozoites with anti-gGlcT1 morpholino oligonucleotide) lowered the gGlcT1 activity by ~40%. Fig. 3B demonstrates that overexpression of gGlcT1 in nonencysting trophozoites causes an increased synthesis of NBD-GlcCer, further suggesting that gGlcT1 activity is directly linked to GlcCer synthesis in Giardia.

FIGURE 3.
Modulation of gGlcT1 activity by overexpression and knockdown. A, stable Giardia cell lines overexpressing GlcT1 enzyme (designated as +GlcT1) were generated by transfecting trophozoites with pNT5-gglct1 (tagged with a small peptide, called AU1) plasmid ...

Next, we asked whether gGlcT1 modulation by overexpression and knockdown also affects the GSL profiles in Giardia. For this, lipids were extracted from overexpressed, knockdown, and rescued trophozoites and subjected to ESI-MS/MS analysis as described under “Experimental Procedures.” Using total ion map and precursor ion scans, we identified both neutral and acidic GSLs that were present in control and gGlcT1-modulated trophozoites. Among the neutral lipids, mono-, di-, and tri-hexosylceramides were identified and found to be altered by gGlcT1 modulation. Although gGlcT1 overexpression increased the amount of mono-hexosylceramide by ~28-fold, the effect was somewhat less (~2-fold) on di-hexosylceramides. Interestingly, no effects of gGlcT1 overexpression were observed in the case of tri-hexosylceramides (Fig. 3C). gGlcT1 knockdown, however, elevated the level of mono-hexosylceramides (~5-fold), and the rescue experiment had no effect, i.e. same as the knockdown (Fig. 3C). Knockdown also decreased the levels of di- and tri-hexosylceramide slightly, and rescue treatment appeared to reverse these effects (Fig. 3C). The analysis of acidic fractions revealed that GM1, GM3, and GD3 lipids are present in control, overexpressed, knockdown, and rescued trophozoites; however, the changes of their levels were not consistent with gGlcT1 modulation (data not shown).

Because ESV synthesis is linked to gGlcT1 activity (Fig. 2), and the fact that PPMP blocks encystation (17, 18), we asked if the modulation of gGlcT1 activity (shown in Fig. 3A) also regulates ESV biogenesis. Fig. 4A, panels b and c, demonstrates that although gGlcT1 overexpression induces the synthesis of aggregated and enlarged ESVs, knockdown of gGlcT1 activity by anti-gGlcT1 morpholino oligonucleotide completely blocks ESV synthesis. More interestingly, the rescue experiment reverses the effects of overexpression and knockdown and generates ESVs (Fig. 4A, panel d) that are comparable with control cells (Fig. 4A, panel a). Again, Fig. 4A, panel e, represents ESVs generated by encysting cells that were treated with scrambled morpholino oligonucleotide, which shows the similar pattern of ESVs found in nontransfected control encysting cells shown in Fig. 4A, panel a. Analysis of individual ESVs is shown in Fig. 4B, demonstrating that gGlcT1 overexpression increases the perimeters and areas of ESVs by ~6- and ~10-fold, respectively. The perimeter and area analyses of individual ESVs were carried out with the help of Zeiss Zen 2009 software (Carl Zeiss) as shown in Fig. 4B.

FIGURE 4.
Modulation of gGlcT1 activity affects ESV biogenesis in Giardia. A, ESV production was monitored in the following:(panel a, control; panel b, GlcT1-overexpressing (+gGlcT1); panel c, antisense, morpholino oligonucleotide-treated gGlcT1-knockdown cells; ...

Anti-gGlcT1 Morpholino Oligonucleotide Does Not Interfere with the Growth and Replication of Trophozoites

PPMP is a common inhibitor of GlcT1 enzyme that has been extensively used to evaluate GlcCer functions in various organisms (41). It has been reported that PPMP blocks replication and cytokinesis of giardial trophozoites and is thereby thought to inhibit the encystation and cyst production in culture (18, 26). We have shown earlier that PPMP interferes with the formation of cysts when it is added in the culture medium during encystation (17). Because our current results show that anti-gGlcT1 morpholino oligonucleotide inhibits gGlcT1 activity and ESV biogenesis (Figs. 3 and and4),4), and because the activity of this enzyme is low in trophozoites and up-regulated in encysting cells, we thought that the effect of PPMP-inhibiting replication and cytokinesis on nonencysting trophozoites might not occur via GlcCer synthesis, as thought previously (18, 26). In fact, there are reports in which PDMP (an analog of PPMP) has been shown to block cell cycle progression in mammalian cells by inhibiting cyclin-dependent kinases, which could be independent of GlcT1 inhibition and ceramide accumulation (42). To address this possibility in Giardia, trophozoites were transfected with morpholino oligonucleotide (anti-gglct1), and the growth was measured as shown in Fig. 5A. Side by side, the growth of the trophozoites in the presence of PPMP (10 μm) was also conducted, and the results showed that although PPMP affects the growth of trophozoites, anti-gGlcT1 morpholino exhibits no effects (Fig. 5A). Fig. 5B, panel b, demonstrates that PPMP, as shown earlier (18, 26), blocks the replication of trophozoites and generates undivided doublet cells. In contrast, anti-gGlcT1 morpholino did not affect the replication of trophozoites (Fig. 5B, panel c). When morpholino-transfected, gGlcT1-knockdown trophozoites were treated with PPMP, the formation of undivided doublets was observed again (Fig. 5B, panel d). The analysis revealed that although ~25% of trophozoites form undivided doublets after PPMP treatment, less than ~5% of doublets was observed in control and anti-gGlcT1 morpholino-treated trophozoites (Fig. 5C). The combined effect of anti-gGlcT1 morpholino and PPMP generated ~20% doublets, as shown in Fig. 5C. These results indicate that PPMP may not act via gGlcT1 in Giardia and that the blocking of cytokinesis in trophozoites by this inhibitor could be through other mechanisms.

FIGURE 5.
Effects of PPMP and anti-gGlcT1 morpholino on growth and replication of trophozoites. A, assessing the growth of trophozoites. Approximately 2 × 105 cells were inoculated into 4-ml tubes containing TYI-S-33 medium, pH 7.1, supplemented with adult ...

Regulated Expression of gGlcT1 Is Critical for Maintaining Cyst Viability

The production of viable cysts is essential for Giardia to establish infection in the small intestine of humans. Earlier reports suggested that cyst morphology is directly correlated with cyst viability, and only viable cysts of Giardia produce infection in mice (43, 44). Gillin et al. (21) reported that in vitro-derived G. lamblia cysts are of two kinds, i.e. type I and type II. The type I cysts are oval shaped with uniform and refractive cyst walls, being mostly (~90%) viable. In contrast, type II cysts lack the morphological characteristics of type I, and a majority (~70%) of them are nonviable. In a heterogeneous cyst population (i.e. a population composed of both type I and type II cysts), ~10–30% of cysts exhibit type I morphology (21, 45). Because we found that the gGlcT1 activity increased during encystation (Fig. 1) and that the modulation of its function (by overexpression and knockdown) regulated ESV biogenesis (Figs. 2 and and4),4), we asked whether gGlcT1 activity is also important for maintaining the cyst morphology and viability. Therefore, trophozoites from various conditions, i.e. control and gGlcT1-overexpressing, gGlcT1 knockdown, and gGlcT1-rescued, were subjected to encystation for 72 h, and the cysts were isolated by centrifugation as described under “Experimental Procedures.” Fig. 6A, panel a, shows control cysts with type I morphology that react with the anti-cyst antibody, which labels the oval-shaped cyst wall. However, this changes significantly in gGlcT1-overexpressing and gGlcT1-knockdown cells (Fig. 6, A, panels b and c). Cysts produced by gGlcT1-overexpressing cells appear to be type II because they are incomplete, clustered, have thin cyst walls, and show minimum reactivity to anti-cyst antibody. Knockdown of gGlcT1 also produces aggregated cryptic cysts; the majority of these cyst-like structures exhibit no reaction to anti-cyst antibody. The rescue treatment, shown in Fig. 6A, panel d, however, produces cysts with well formed cyst walls that react with the cyst antibody. Because the morphology could be an indicative of viability (43, 45), our next goal was to test if the viability of cysts is affected by gGlcT1 overexpression and knockdown. The viable and nonviable cysts were identified by staining with fluorogenic dyes, i.e. cell-permeable esterase substrate FDA and the cell impermeant nucleic acid stain PI, which were earlier used by other laboratories to determine the viability of giardial cysts (21, 43, 44). Fig. 6B indicates that although in control samples ~12% of cysts were viable, only ~8 and ~3% of cysts were viable in gGlcT1-overexpressing and gGlcT1-knockdown cells, respectively. Most importantly, the rescue experiment, in which the effect of gGlcT1 was neutralized by the anti-gGlcT1 morpholino analog, recovers the cyst and increases the viability up to ~10%. This is an important observation and strongly suggests that gGlcT1 activity in Giardia not only regulates ESV biogenesis but also maintains the cyst viability. Although it appears that these numbers of viable cysts are somewhat low, our calculation is based on the total number of water-resistant cysts that contain all types of cysts, including type I and type II. Thus, viability estimations, shown here, are within the expected range and in accordance with the report published by Gillin et al. (21) and Boucher et al. (45).

FIGURE 6.
gGlcT1 activity regulates the morphology and viability of in vitro-derived cysts. A, trophozoites were subjected to encystation as described under “Experimental Procedures” for 72 h. Cysts were harvested by centrifugation, kept in cold ...

gGlcT1 Overexpression Alters Lipid Balance in Trophozoites

As proposed earlier, Giardia trophozoites have limited abilities to synthesize membrane lipids, cholesterol, and fatty acids de novo and thus depend on supplies from the small intestines, where the trophozoites colonize (46, 47). Studies suggest that most of the lipids and fatty acids are taken up by this parasite from outside sources and are utilized for energy metabolism and biogenesis of organelles and vesicles (4850). Because gGlcT1 overexpression induces the synthesis of enlarged vesicles and produces cysts with reduced viability (Figs. 2, ,4,4, and and6),6), we investigated whether gGlcT1 expression is associated with increased lipid uptake by Giardia trophozoites. We asked whether gGlcT1 expression is linked to an increased influx of membrane lipids and whether the intracellular levels of cholesterol and fatty acid are altered by gGlcT1, which in turn would affect the membrane fluidity and lipid uptake.

gGlcT1 Overexpression Affects the Internalization and Intracellular Targeting of Fluorescent Lipids

Using fluorescently labeled (Bodipy or NBD) lipid and fatty acid analogs, we have shown earlier that trophozoites have the machinery to recruit lipids from their environment and target them into specific cellular locations, including the plasma membrane and endomembranes, as well as the cytoplasm (28). For example, ceramide and PG were found to be localized at ER/perinuclear membranes, and PC was incorporated into plasma and flagellar membranes of trophozoites. We found exogenous SM were targeted into nuclear and plasma membranes and PE in the inner layer of the plasma membrane (51, 52). Furthermore, it was shown by us earlier that ceramide is taken up by Giardia via a clathrin-dependent pathway and is likely to be regulated by giardial serine palmitoyltransferase, a rate-determining enzyme of SL biosynthesis (17, 49). The internalization of various fluorescent lipid probes, including Bodipy-ceramide, NBD-SM, Bodipy-PG, Bodipy-PC, NBD-PE, and FAST Dil (a common lipid-labeling dye), was studied in control and gGlcT1-overexpressing trophozoites. The results demonstrated that gGlcT1 overexpression increased the uptake and labeling intensities of ceramide, SM, PG, PE, and FAST Dil (Fig. 7A). Interestingly, PE, which is located in the inner plasma membranes, migrates inside the cells and is concentrated in the ER/perinuclear membranes (Fig. 7, A, panels i and j), whereas PC, another major lipid of the plasma membrane, is not affected by gGlcT1 (Fig. 7A, panels e and f). The labeling by FAST Dil (which labels the lipids in plasma and intracellular membranes) is also increased in gGlcT1-overexpressing cells (Fig. 7A, panels k and l). These results suggest that gGlcT1 activity is responsible for the influx of majority of cellular lipids in Giardia.

FIGURE 7.
gGlcT1 overexpression increases the influx of fluorescent lipids in trophozoites. A, trophozoites (control or +gGlcT1) were labeled with various fluorescent lipid probes for 1 h at 37 °C following the methods described under “Experimental ...

gGlcT1 Overexpression Elevates the Intracellular Levels of Cholesterol and Fatty Acid in Trophozoites

Like other lipid molecules, Giardia also has a limited ability to synthesize cholesterol and fatty acids de novo, which are obtained from the growth medium. Interestingly, both cholesterol and fatty acids have been shown to be involved in regulating encystation and cyst formation by this waterborne pathogen (48, 53, 54). As gGlcT1 overexpression increased the internalization of fluorescent lipid probes from the medium (Fig. 7), we thought it would be important to examine whether gGlcT1 expression also changes the cellular fatty acid and cholesterol levels. Cholesterol and free fatty acids in control and gGlcT1-overexpressing cells were analyzed by GC-MS. The sterol analysis showed that cholesterol is the major sterol in both control and gGlcT1-overexpressing cells (Fig. 8A), and no other sterols, including cholesteryl esters or ergosterol, were detected (55). It is interesting that gGlcT1 overexpression increased the intracellular level of cholesterol by ~2-fold. Fatty acid analysis (Fig. 8B) revealed that palmitic acid, stearic acid, oleic acid, and linoleic acid were the major fatty acids present in Giardia trophozoites and that gGlcT1 overexpression increased the level of these fatty acids by ~20, ~22, ~25, and ~38%, respectively. Thus, as with other lipids as shown in Fig. 7, gGlcT1 expression also increased the uptake of cholesterol and fatty acids by Giardia (Fig. 8, A and B)

FIGURE 8.
gGlcT1 overexpression increases cholesterol and fatty acid levels but does not alter membrane fluidity. Control and gGlcT1-overexpressing Giardia were subjected to Folch's partition and subsequent fractionation to separate sterols and fatty acids. A, ...

Because the changing of membrane fluidity may increase lipid uptake by trophozoites, we investigated the possibility that the membrane fluidity could be modified due to the up-regulation of cholesterol and fatty acids by GlcT1, allowing the cells to internalize excess fluorescent lipids as shown in Fig. 7. The membrane fluidity was measured using a fluorescent lipid probe, pyrene decanoic acid, as detailed under “Experimental Procedures.” This pyrene probe usually forms excimer by interacting with membrane components that cause a shift of emission spectrum to a longer wavelength. Therefore, the ratio of monomer to excimer shift could be utilized to measure the change of membrane fluidity (described by the manufacturer, Marker Gene Technologies). Fig. 8C shows that gGlcT1 overexpression did not produce pyrene excimers from monomers. However, the trophozoites treated at 4 °C (cold-shock) showed significant changes from monomer to excimer of the pyrene probe (Fig. 8D). This suggests that the fluidity of trophozoite plasma membranes is not affected by gGlcT1 overexpression, although it increased the uptake of lipid, cholesterol, and fatty acids. We speculate that the increased lipid uptake by gGlcT1-overexpressed trophozoites occurs via receptor- or raft-mediated lipid endocytosis (48, 49) rather than to the change of membrane fluidity.

DISCUSSION

In this study, we show that gGlcT1 activity is important in the production of viable cysts by Giardia and that it acts by regulating ESV biogenesis and controlling the import of lipids and fatty acids from the environment.

Several strategies were followed to modulate gGlcT1 activity in Giardia. First, gGlcT1-knockdown trophozoites were generated (using anti-gglct1 morpholino oligonucleotide), which reduced the activity of gGlcT1 in both cysts and trophozoites (Figs. 1B and and33A). Second, the gglct1 gene was overexpressed in trophozoites, and this caused an elevation of enzyme activity by ~3-fold (Fig. 3A). Third, the increased gGlcT1 activity in overexpressed cells was rescued by knocking down the gene using morpholino oligonucleotide, which reduced the excess activity caused by the overexpression of the gglct1 gene (Fig. 3A). We found that the modulation of gGlcT1 activity directly correlated with ESV biogenesis (Fig. 4). When the excess gGlcT1 activity in gGlcT1-overexpressing cells was normalized by introducing anti-gglct1 morpholino oligonucleotide, ESV synthesis was restored and appeared to be normal as judged by confocal microscopy as well as by analyzing the perimeter and area of individual ESVs (Fig. 4). These results suggest that gGlcT1 directly influences the secretion and maturation of ESVs, which are critical for cyst production/viability. This postulation can be further supported by our cyst experiment, in which the rescue treatment generated classical oval-shaped cysts with thick cyst walls that are similar in morphology and viability to control cysts (Fig. 6).

To identify the possible mechanism how gGlcT1 regulates ESV biogenesis and cyst production, we investigated the overall lipid balance in gGlcT1-overexpressing trophozoites. Our results showed that the elevated gGlcT1 activity caused an increased uptake of mono-hexosylceramides, fluorescent lipids, cholesterol, and fatty acids (Figs. 3C, ,7,7, and and8).8). The rising levels of mono-hexosylceramide in gGlcT1-overexpressed cells can also be caused by the de novo synthesis of these molecules (catalyzed by an active gGlcT1 enzyme) in addition to the increased uptake from the growth medium (Fig. 3C). Therefore, it is likely that Giardia uses its gGlcT1 enzyme to maintain an overall lipid balance by importing a majority of lipids from outside and synthesizing a selective few (5054). We propose that the controlled expression of gGlcT1 is critical for lipid internalization in trophozoites because overexpression or knocking down of this enzyme affects ESV biogenesis and cyst viability. The observation that gGlcT1 regulates the overall lipid balance/homeostasis in Giardia was further supported by the report that GlcT1 overexpression influences several body fat storage genes in Drosophila (56) and also that the interactions between SL and other branches of the lipid metabolic pathways are essential for maintaining lipid homeostasis in mammalian cells (57, 58).

As far as the effect of PPMP on Giardia trophozoites is concerned, it has been reported (18, 26) that this inhibitor interferes with the replication and cytokinesis of trophozoites and thereby blocks encystation. This action of PPMP has been attributed to GlcT1 inhibition and intracellular ceramide accumulation (26). In contrast, we observed that anti-gglct1 morpholino oligonucleotide treatment did not reduce the growth and replication of Giardia trophozoites (Fig. 5), but it did inhibit ESV biogenesis and cyst production when subjected to encystation. Although we did not measure the intracellular concentration of ceramide after PPMP treatment, there is evidence that another GlcT1 inhibitor, PDMP, can influence the cell cycle regulation by inhibiting cyclin-dependent kinases and not exclusively by inhibiting GlcCer synthesis. Detailed analysis revealed that PDMP treatment caused a reversible decrease in the activity of cyclin-dependent kinases (i.e. cdk2 and p34cdc2), which led to cell cycle arrest (42, 59, 60). Thus, it is possible that PPMP-induced blocking of trophozoite replication and cytokinesis could be an off-target effect that is caused by the inhibition of giardial cell cycle proteins and kinases (61) rather than the inhibition of GlcT1 and accumulation of ceramide. However, more in-depth experiments should be undertaken to resolve this issue.

Although in our study it is not clear why cyst stage gGlcT1 is not inhibited by PPMP (Fig. 1), Stefanić et al. (26) reported that Giardia synthesizes di- and tri-hexosylceramides in encysting cells and cysts. Hillig et al. (62) also reported that GCS in plant cells shows broader substrate affinities and functions as a sterol glucoside synthase. Interestingly, gGlcT1 and plant GCS are remarkably similar as far as the amino acid identity and sequence motifs are concerned (26), and therefore, like plant GCS, gGlcT1 may exhibit broader substrate preferences and catalyze the synthesis of di- and tri-hexosylceramides as shown in Fig. 3C. We observed that knockdown of gGlcT1 activity by anti-gGlcT1 morpholino also elevated the levels of mono-hexosylceramides over control trophozoites, which could probably be due to membrane damage caused by the electroporation that allows cells to uptake excess mono-hexosylceramides from the medium (Fig. 3C). This conclusion is based on our observation that the mono-hexosylceramide level also increases in trophozoites that are transfected with scrambled morpholino oligonucleotides (data not shown).

Earlier studies identified and characterized an enzyme, i.e. cyst wall synthase (N-acetylgalactosaminyltransferase), which is involved in the formation of insoluble N-acetyl-galactosamine homopolymer, a major component of the giardial cyst wall (63). It is likely that cyst gGlcT1 interacts with cyst wall synthase and facilitates the process of cyst production. However, detailed experiments are necessary to characterize the GlcT1 activity in cysts and the classes of complex glycosphingolipids that are formed during encystation. Moreover, there are instances where GSLs have been shown to be involved in maintaining the growth and morphology of mammalian cells. For example, GSL-deficient B16 melanoma cells exhibit altered morphology and slower growth rates (64). GlcCer synthesis is also necessary for preserving the virulence of infective fungal cells (65, 66). Thus, based on these observations, we propose that gGlcT1, like fungal cells, is an important pathogenic determinant of this parasite and should be targeted for developing new drugs to control giardiasis. The result that gGlcT1 is critical for maintaining cyst viability shown in this study should open a new possibility for investigation of whether gGlcT1-knockdown cysts with reduced viability can also be utilized as a live vaccine candidate to control giardiasis.

Acknowledgments

GC-MS, ESI-MS/MS, confocal microscopy, sequencing, and statistical analyses were carried out in the Biomolecule Analysis, Genomic Analysis, Cytometry, Screening and Imaging, and Statistical Consulting Core Facilities at the Border Biomedical Research Center, University of Texas at El Paso, supported by National Institutes of Health Grant G12MD007592 from the National Institutes of Minority Health and Disparity. We thank Dr. Julia Bader for helping us with statistical analysis and Dr. Armando Varela for help with confocal microscopy. We also thank Dr. Chin-Hung Sun (Taiwan) for providing us with pNT5 expression plasmid.

*This work was supported, in whole or in part, by National Institutes of Health Grant R01AI 095667 (S.D.).

3The abbreviations used are:

ESV
encystation-specific vesicle
CWP
cyst wall protein
GlcCer
glucosylceramide
GlcT1
glucosylceramide transferase 1
gGlcT1
giardial glucosylceramide transferase-1
GCS
glucosylceramide synthase
SL
sphingolipid
GM1
mono-sialotetrahexosylceramide
GM3
mono-sialodihexosylceramide
GD3
di-sialodihexosylceramide
SPT
serine palmitoyltransferase
PPMP
d-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
PDMP
d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol
NBD
N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]
Bodipy
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
PC
phosphatidylcholine
PG
phosphatidylglycerol
PE
phosphatidylethanolamine
SM
sphingomyelin
FDA
fluorescein diacetate
PI
propidium iodide
FAST Dil
1,1′-dilinoleyl-3,3,3′,3′-tetramethylindocarboxyanine
ESI
electrospray ionization
GSL
glycosphingolipid
ER
endoplasmic reticulum.

REFERENCES

1. Adam R. D. (2001) Biology of Giardia lamblia. Clin. Microbiol. Rev. 14, 447–475 [PMC free article] [PubMed]
2. Das S., Gillin F. D. (1996) Giardia lamblia: increased UDP-N-acetyl-d-glucosamine and N-acetyl-d-galactosamine transferase activities during encystation. Exp. Parasitol. 83, 19–29 [PubMed]
3. Gerwig G. J., van Kuik J. A., Leeflang B. R., Kamerling J. P., Vliegenthart J. F., Karr C. D., Jarroll E. L. (2002) The Giardia intestinalis filamentous cyst wall contains a novel β(1–3)-N-acetyl-d-galactosamine polymer: a structural and conformational study. Glycobiology 12, 499–505 [PubMed]
4. Sener K., Shen Z., Newburg D. S., Jarroll E. L. (2004) Amino sugar phosphate levels in Giardia change during cyst wall formation. Microbiology 150, 1225–1230 [PubMed]
5. Lauwaet T., Davids B. J., Reiner D. S., Gillin F. D. (2007) Encystation of Giardia lamblia: a model for other parasites. Curr. Opin. Microbiol. 10, 554–559 [PMC free article] [PubMed]
6. Mowatt M. R., Luján H. D., Cotten D. B., Bowers B., Yee J., Nash T. E., Stibbs H. H. (1995) Developmentally regulated expression of a Giardia lamblia cyst wall protein gene. Mol. Microbiol. 15, 955–963 [PubMed]
7. Luján H. D., Mowatt M. R., Conrad J. T., Bowers B., Nash T. E. (1995) Identification of a novel Giardia lamblia cyst wall protein with leucine-rich repeats. Implications for secretory granule formation and protein assembly into the cyst wall. J. Biol. Chem. 270, 29307–29313 [PubMed]
8. Gottig N., Elías E. V., Quiroga R., Nores M. J., Solari A. J., Touz M. C., Luján H. D. (2006) Active and passive mechanisms drive secretory granule biogenesis during differentiation of the intestinal parasite Giardia lamblia. J. Biol. Chem. 281, 18156–18166 [PubMed]
9. DuBois K. N., Abodeely M., Sakanari J., Craik C. S., Lee M., McKerrow J. H., Sajid M. (2008) Identification of the major cysteine protease of Giardia and its role in encystation. J. Biol. Chem. 283, 18024–18031 [PMC free article] [PubMed]
10. Separovic D., Breen P., Joseph N., Bielawski J., Pierce J. S., VAN Buren E., Gudz T. I. (2012) Ceramide synthase 6 knockdown suppresses apoptosis after photodynamic therapy in human head and neck squamous carcinoma cells. Anticancer Res 32, 753–760 [PubMed]
11. Gu Y., Forostyan T., Sabbadini R., Rosenblatt J. (2011) Epithelial cell extrusion requires the sphingosine 1-phosphate receptor 2 pathway. J. Cell Biol. 193, 667–676 [PMC free article] [PubMed]
12. Acharya U., Patel S., Koundakjian E., Nagashima K., Han X., Acharya J. K. (2003) Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science 299, 1740–1743 [PubMed]
13. Gable K., Gupta S. D., Han G., Niranjanakumari S., Harmon J. M., Dunn T. M. (2010) A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity. J. Biol. Chem. 285, 22846–22852 [PMC free article] [PubMed]
14. Pata M. O., Hannun Y. A., Ng C. K. (2010) Plant sphingolipids: decoding the enigma of the Sphinx. New Phytol. 185, 611–630 [PMC free article] [PubMed]
15. Dickson R. C. (2008) Thematic review series: sphingolipids. New insights into sphingolipid metabolism and function in budding yeast. J. Lipid Res. 49, 909–921 [PMC free article] [PubMed]
16. Zhang K., Bangs J. D., Beverley S. M. (2010) Sphingolipids in parasitic protozoa. Adv. Exp. Med. Biol. 688, 238–248 [PMC free article] [PubMed]
17. Hernandez Y., Shpak M., Duarte T. T., Mendez T. L., Maldonado R. A., Roychowdhury S., Rodrigues M. L., Das S. (2008) Novel role of sphingolipid synthesis genes in regulating giardial encystation. Infect. Immun. 76, 2939–2949 [PMC free article] [PubMed]
18. Sonda S., Stefanic S., Hehl A. B. (2008) A sphingolipid inhibitor induces a cytokinesis arrest and blocks stage differentiation in Giardia lamblia. Antimicrob. Agents Chemother. 52, 563–569 [PMC free article] [PubMed]
19. Diamond L. S., Harlow D. R., Cunnick C. C. (1978) A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 72, 431–432 [PubMed]
20. Keister D. B. (1983) Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans. R. Soc. Trop. Med. Hyg. 77, 487–488 [PubMed]
21. Gillin F. D., Boucher S. E., Rossi S. S., Reiner D. S. (1989) Giardia lamblia: the roles of bile, lactic acid, and pH in the completion of the life cycle in vitro. Exp. Parasitol. 69, 164–174 [PubMed]
22. Pan Y. J., Cho C. C., Kao Y. Y., Sun C. H. (2009) A novel WRKY-like protein involved in transcriptional activation of cyst wall protein genes in Giardia lamblia. J. Biol. Chem. 284, 17975–17988 [PMC free article] [PubMed]
23. Carpenter M. L., Cande W. Z. (2009) Using morpholinos for gene knockdown in Giardia intestinalis. Eukaryot. Cell 8, 916–919 [PMC free article] [PubMed]
24. Uchida Y., Murata S., Schmuth M., Behne M. J., Lee J. D., Ichikawa S., Elias P. M., Hirabayashi Y., Holleran W. M. (2002) Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress. J. Lipid Res. 43, 1293–1302 [PubMed]
25. Couto A. S., Caffaro C., Uhrig M. L., Kimura E., Peres V. J., Merino E. F., Katzin A. M., Nishioka M., Nonami H., Erra-Balsells R. (2004) Glycosphingolipids in Plasmodium falciparum. Presence of an active glucosylceramide synthase. Eur. J. Biochem. 271, 2204–2214 [PubMed]
26. Stefanić S., Spycher C., Morf L., Fabriàs G., Casas J., Schraner E., Wild P., Hehl A. B., Sonda S. (2010) Glucosylceramide synthesis inhibition affects cell cycle progression, membrane trafficking, and stage differentiation in Giardia lamblia. J. Lipid Res. 51, 2527–2545 [PMC free article] [PubMed]
27. Gupta V., Patwardhan G. A., Zhang Q. J., Cabot M. C., Jazwinski S. M., Liu Y. Y. (2010) Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase. J. Lipid Res. 51, 866–874 [PMC free article] [PubMed]
28. Stevens T. L., Gibson G. R., Adam R., Maier J., Allison-Ennis M., Das S. (1997) Uptake and cellular localization of exogenous lipids by Giardia lamblia, a primitive eukaryote. Exp. Parasitol. 86, 133–143 [PubMed]
29. Fridberg A., Olson C. L., Nakayasu E. S., Tyler K. M., Almeida I. C., Engman D. M. (2008) Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei. J. Cell Sci. 121, 522–535 [PubMed]
30. Pernet F., Pelletier C. J., Milley J. (2006) Comparison of three solid-phase extraction methods for fatty acid analysis of lipid fractions in tissues of marine bivalves. J. Chromatogr. A 1137, 127–137 [PubMed]
31. Maldonado R. A., Kuniyoshi R. K., Linss J. G., Almeida I. C. (2006) Trypanosoma cruzi oleate desaturase: molecular characterization and comparative analysis in other trypanosomatids. J. Parasitol. 92, 1064–1074 [PubMed]
32. Li Y., Zhou D., Xia C., Wang P. G., Levery S. B. (2008) Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry. Glycobiology 18, 166–176 [PubMed]
33. Ciucanu I., Kerek F. J. (1984) A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 131, 209–217
34. Kovács P., Pintér M., Csaba G. (2000) Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis: data on the evolution of the signaling system. Cell Biochem. Funct. 18, 269–280 [PubMed]
35. Shukla A., Radin N. S. (1991) Metabolism of d-[3H]threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, and the synergistic action of an inhibitor of microsomal monooxygenase. J. Lipid Res. 32, 713–722 [PubMed]
36. House S. A., Richter D. J., Pham J. K., Dawson S. C. (2011) Giardia flagellar motility is not directly required to maintain attachment to surfaces. PLoS Pathog. 7, e1002167. [PMC free article] [PubMed]
37. Bittencourt-Silvestre J., Lemgruber L., de Souza W. (2010) Encystation process of Giardia lamblia: morphological and regulatory aspects. Arch. Microbiol. 192, 259–265 [PubMed]
38. McCaffery J. M., Gillin F. D. (1994) Giardia lamblia: ultrastructural basis of protein transport during growth and encystation. Exp. Parasitol. 79, 220–235 [PubMed]
39. Stefanic S., Morf L., Kulangara C., Regös A., Sonda S., Schraner E., Spycher C., Wild P., Hehl A. B. (2009) Neogenesis and maturation of transient Golgi-like cisternae in a simple eukaryote. J. Cell Sci. 122, 2846–2856 [PubMed]
40. Hehl A. B., Marti M. (2004) Secretory protein trafficking in Giardia intestinalis. Mol. Microbiol. 53, 19–28 [PubMed]
41. Atilla-Gokcumen G. E., Bedigian A. V., Sasse S., Eggert U. S. (2011) Inhibition of glycosphingolipid biosynthesis induces cytokinesis failure. J. Am. Chem. Soc. 133, 10010–10013 [PMC free article] [PubMed]
42. Rani C. S., Abe A., Chang Y., Rosenzweig N., Saltiel A. R., Radin N. S., Shayman J. A. (1995) Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J. Biol. Chem. 270, 2859–2867 [PubMed]
43. Schupp D. G., Erlandsen S. L. (1987) A new method to determine Giardia cyst viability: correlation of fluorescein diacetate and propidium iodide staining with animal infectivity. Appl. Environ. Microbiol. 53, 704–707 [PMC free article] [PubMed]
44. Schupp D. G., Erlandsen S. L. (1987) Determination of Giardia muris cyst viability by differential interference contrast, phase, or brightfield microscopy. J. Parasitol. 73, 723–729 [PubMed]
45. Boucher S. E., Gillin F. D. (1990) Excystation of in vitro-derived Giardia lamblia cysts. Infect. Immun. 58, 3516–3522 [PMC free article] [PubMed]
46. Jarroll E. L., Muller P. J., Meyer E. A., Morse S. A. (1981) Lipid and carbohydrate metabolism of Giardia lamblia. Mol. Biochem. Parasitol. 2, 187–196 [PubMed]
47. Das S., Stevens T., Castillo C., Villasenõr A., Arredondo H., Reddy K. (2002) Lipid metabolism in mucous-dwelling amitochondriate protozoa. Int. J. Parasitol. 32, 655–675 [PubMed]
48. Lujan H. D., Mowatt M. R., Nash T. E. (1996) Lipid requirements and lipid uptake by Giardia lamblia trophozoites in culture. J. Eukaryot. Microbiol. 43, 237–242 [PubMed]
49. Hernandez Y., Castillo C., Roychowdhury S., Hehl A., Aley S. B., Das S. (2007) Clathrin-dependent pathways and the cytoskeleton network are involved in ceramide endocytosis by a parasitic protozoan, Giardia lamblia. Int. J. Parasitol. 37, 21–32 [PMC free article] [PubMed]
50. Yichoy M., Duarte T. T., De Chatterjee A., Mendez T. L., Aguilera K. Y., Roy D., Roychowdhury S., Aley S. B., Das S. (2011) Lipid metabolism in Giardia: a post-genomic perspective. Parasitology 138, 267–278 [PMC free article] [PubMed]
51. Gibson G. R., Ramirez D., Maier J., Castillo C., Das S. (1999) Giardia lamblia: incorporation of free and conjugated fatty acids into glycerol-based phospholipids. Exp. Parasitol. 92, 1–11 [PubMed]
52. Das S., Castillo C., Stevens T. (2001) Phospholipid remodeling/generation in Giardia: the role of the Lands cycle. Trends Parasitol. 17, 316–319 [PubMed]
53. Luján H. D., Mowatt M. R., Byrd L. G., Nash T. E. (1996) Cholesterol starvation induces differentiation of the intestinal parasite Giardia lamblia. Proc. Natl. Acad. Sci. U.S.A. 93, 7628–7633 [PubMed]
54. Yichoy M., Nakayasu E. S., Shpak M., Aguilar C., Aley S. B., Almeida I. C., Das S. (2009) Lipidomic analysis reveals that phosphatidylglycerol and phosphatidylethanolamine are newly generated phospholipids in an early-divergent protozoan, Giardia lamblia. Mol. Biochem. Parasitol. 165, 67–78 [PMC free article] [PubMed]
55. Ellis J. E., Wyder M. A., Jarroll E. L., Kaneshiro E. S. (1996) Changes in lipid composition during in vitro encystation and fatty acid desaturase activity of Giardia lamblia. Mol. Biochem. Parasitol. 81, 13–25 [PubMed]
56. Kohyama-Koganeya A., Nabetani T., Miura M., Hirabayashi Y. (2011) Glucosylceramide synthase in the fat body controls energy metabolism in Drosophila. J. Lipid Res. 52, 1392–1399 [PMC free article] [PubMed]
57. Bektas M., Allende M. L., Lee B. G., Chen W., Amar M. J., Remaley A. T., Saba J. D., Proia R. L. (2010) Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. J. Biol. Chem. 285, 10880–10889 [PMC free article] [PubMed]
58. Pewzner-Jung Y., Park H., Laviad E. L., Silva L. C., Lahiri S., Stiban J., Erez-Roman R., Brügger B., Sachsenheimer T., Wieland F., Prieto M., Merrill A. H., Jr., Futerman A. H. (2010) A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways. J. Biol. Chem. 285, 10902–10910 [PMC free article] [PubMed]
59. Norris-Cervetto E., Callaghan R., Platt F. M., Dwek R. A., Butters T. D. (2004) Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells. J. Biol. Chem. 279, 40412–40418 [PubMed]
60. Dijkhuis A. J., Klappe K., Jacobs S., Kroesen B. J., Kamps W., Sietsma H., Kok J. W. (2006) PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Mol. Cancer Ther. 5, 593–601 [PubMed]
61. Reiner D. S., Ankarklev J., Troell K., Palm D., Bernander R., Gillin F. D., Andersson J. O., Svärd S. G. (2008) Synchronisation of Giardia lamblia: identification of cell cycle stage-specific genes and a differentiation restriction point. Int. J. Parasitol. 38, 935–944 [PubMed]
62. Hillig I., Leipelt M., Ott C., Zähringer U., Warnecke D., Heinz E. (2003) Formation of glucosylceramide and sterol glucoside by a UDP-glucose-dependent glucosylceramide synthase from cotton expressed in Pichia pastoris. FEBS Lett. 553, 365–369 [PubMed]
63. Jarroll E. L., Macechko P. T., Steimle P. A., Bulik D., Karr C. D., van Keulen H., Paget T. A., Gerwig G., Kamerling J., Vliegenthart J., Erlandsen S. (2001) Regulation of carbohydrate metabolism during Giardia encystment. J. Eukaryot. Microbiol. 48, 22–26 [PubMed]
64. Ichikawa S., Nakajo N., Sakiyama H., Hirabayashi Y. (1994) A mouse B16 melanoma mutant deficient in glycolipids. Proc. Natl. Acad. Sci. U.S.A. 91, 2703–2707 [PubMed]
65. Noble S. M., French S., Kohn L. A., Chen V., Johnson A. D. (2010) Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42, 590–598 [PMC free article] [PubMed]
66. Rittershaus P. C., Kechichian T. B., Allegood J. C., Merrill A. H., Jr., Hennig M., Luberto C., Del Poeta M. (2006) Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Invest. 116, 1651–1659 [PMC free article] [PubMed]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology